Jim Simons' Renaissance Technologies Chops Position in Buffett's Apple

Private investment firm releases its 1st-quarter portfolio update

Author's Avatar
May 24, 2023
Summary
  • Firm chopped its positions in Apple and Taiwan Semiconductor Manufacturing.
  • It also exited its holdings of Advanced Micro Devices and Alphabet.
  • The firm boosted its investments in Boeing, Pfizer and UnitedHealth Group.
Article's Main Image

Renaissance Technologies, the firm founded by Jim Simons (Trades, Portfolio), disclosed in a regulatory 13F filing that its top trades during the first quarter included reductions to its positions in Apple Inc. (AAPL, Financial) and Taiwan Semiconductor Manufacturing Co. Ltd. (TSM, Financial) and the closure of its positions in Advanced Micro Devices Inc. (AMD, Financial) and Alphabet Inc. (GOOGL, Financial). With the proceeds, the firm boosted its holdings of Boeing Co. (BA, Financial), Pfizer Inc. (PFE, Financial) and UnitedHealth Group Inc. (UNH, Financial).

The New York-based firm applies complex mathematical models to analyze and execute trades, many of them automated. Renaissance predicts price movements in financial instruments by using models that are based on gathering as much data as possible and then looking for non-random movements to make predictions.

1661109237100576768.png

As of March, the firm’s $75.35 billion 13F equity portfolio contains 3,924 stocks, with 529 new positions and a quarterly turnover ratio of 23%. The top four sectors in terms of weight are health care, technology, consumer cyclical and industrials, representing19.97%, 16.25%, 12.33% and 10.40% of the equity portfolio.

1661109755449442304.png

Investors should be aware 13F filings do not give a complete picture of a firm’s holdings as the reports only include its positions in U.S. stocks and American depository receipts, but they can still provide valuable information. Further, the reports only reflect trades and holdings as of the most-recent portfolio filing date, which may or may not be held by the reporting firm today or even when this article was published.

Apple

Renaissance sold 7,090,086 shares of Apple (AAPL, Financial), chopping 99.87% of the position and 1.26% of its equity portfolio.

1661111607146577920.png

Shares of Apple averaged $147.55 during the fourth quarter; the stock is fairly valued based on its price-to-GF Value of approximately 1 as of Wednesday.

1661113231894118400.png

The Cupertino, California-based consumer electronics giant has a GF Score of 96 out of 100 based on a financial strength rank of 7 out of 10, a GF Value rank of 5 out of 10 and a rank of 10 out of 10 for momentum, profitability and growth.

1661117571530752000.png

Apple’s high profitability rank is driven by several positive investing signs, which include a five-star business predictability rank and an operating margin that has increased by approximately 2.7% per year on average over the past five years and outperforms more than 97% of global competitors.

1661125576380907520.png

Warren Buffett (Trades, Portfolio)’s Berkshire Hathaway Inc. (BRK.A, Financial)(BRK.B, Financial) owns 915,560,382 shares of Apple, giving the stake 46.44% weight in its 13F equity portfolio. The position has been Berkshire’s top holding since December 2017.

1661126358635380736.png

Taiwan Semiconductor Manufacturing

Renaissance sold 4,913,600 shares of Taiwan Semiconductor Manufacturing (TSM, Financial), slicing 64.85% of the position and 0.50% of its equity portfolio.

1661126767735209984.png

Shares of Taiwan Semiconductor Manufacturing averaged $89.76 during the first quarter; the stock is significantly undervalued based on its price-to-GF Value ratio of 0.63 as of Wednesday.

1661127093422915584.png

The Taiwanese chipmaker has a GF Score of 99 out of 100 based on a rank of 8 out of 10 for financial strength and momentum and a rank of 10 out of 10 for profitability, growth and GF Value.

1661128703989514240.png

Berkshire sold all 8,292,724 shares of Taiwan Semiconductor Manufacturing, reducing its equity portfolio by 0.21%.

1661130006690004992.png

Advanced Micro Devices

The firm sold all 6,905,890 shares of Advanced Micro Devices (AMD, Financial), trimming 0.61% of its equity portfolio.

1661393938063294464.png

Shares of Advanced Micro Devices averaged $81.38 during the first quarter; the stock is modestly undervalued based on its price-to-GF Value ratio of 0.83 as of Wednesday.

1661394255135899648.png

The Santa Clara, California-based microprocessor company has a GF Score of 92 out of 100 based on a rank of 8 out of 10 for momentum and financial strength, a growth rank of 10 out of 10 and a rank of 7 out of 10 for profitability and GF Value.

1661397846508699648.png

Alphabet

Renaissance sold all 4,218,455 Class A shares of Alphabet (GOOGL, Financial), reducing its equity portfolio by 0.51%.

1661401863414611968.png

Shares of Alphabet averaged $95.94 during the first quarter; the stock is modestly undervalued based on its price-to-GF Value ratio of 0.82 as of Wednesday.

1661086387320913920.png

The Mountain View, California-based online search giant has a GF Score of 99 out of 100 based on a rank of 10 out of 10 for profitability and growth, a financial strength rank of 9 out of 10, a momentum rank of 8 out of 10 and a GF Value rank of 7 out of 10.

1660715250875367424.png

Alphabet’s high profitability rank is driven by several positive investing signs, which include a 4.5-star business predictability rank and an operating margin that has increased by approximately 2.40% per year on average over the past five years.

1660729044188004352.png

Boeing

The firm added 2,370,800 shares of Boeing (BA, Financial), expanding the position by 1,071.31% and its equity portfolio by 0.67%.

1661402959688237056.png

Shares of Boeing averaged $207.77 during the first quarter; the stock is modestly undervalued based on its price-to-GF Value ratio of 0.91 as of Wednesday.

1661405065774104576.png

The Arlington, Virginia-based aerospace giant has a GF Score of 65 out of 100 based on a momentum rank of 9 out of 10, a profitability rank of 6 out of 10, a GF Value rank of 5 out of 10, a financial strength rank of 3 out of 10 and a growth rank of 1 out of 10.

1661408785249337344.png

Pfizer

The firm invested in 11,078,514 shares of Pfizer (PFE, Financial), boosting the position by 1,033.98% and its equity portfolio by 0.60%.

1661410040113790976.png

Shares of Pfizer averaged $43.19 during the first quarter; the stock is significantly undervalued based on its price-to-GF Value ratio of 0.56 as of Wednesday.

1661410453026242560.png

The New York-based pharmaceutical company has a GF Score of 86 out of 100 based on a rank of 9 out of 10 for profitability and growth, a GF Value rank of 8 out of 10, a financial strength rank of 7 out of 10 and a momentum rank of 2 out of 10.

1661414325283192832.png

UnitedHealth Group

Renaissance purchased 912,256 shares of UnitedHealth Group (UNH, Financial), boosting the position by 169.35% and its equity portfolio by 0.57%.

1661436287271305216.png

Shares of UnitedHealth Group averaged $482.57 during the first quarter; the stock is modestly undervalued based on its price-to-GF Value ratio of 0.89 as of Wednesday.

1661436844258099200.png

The Minnetonka, Minnesota-based health insurance company has a GF Score of 95 out of 100 based on a rank of 10 out of 10 for profitability and growth, a financial strength rank of 7 out of 10, a GF Value rank of 6 out of 10 and a momentum rank of 5 out of 10.

1661441421774684160.png

Disclosures

I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours. Click for the complete disclosure